Cargando…

Long Non-Coding RNA THOR Enhances the Stem Cell-Like Traits of Triple-Negative Breast Cancer Cells Through Activating β-Catenin Signaling

BACKGROUND: The oncogenic roles of lncRNA THOR have been revealed in several tumors, however, its functions in breast cancer are still unclear. MATERIAL/METHODS: Real-time quantitative polymerase chain reaction (RT-qPCR) was used to detect THOR expression in clinical samples and the expression of st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Binbin, Ye, Qiang, Zou, Chuantao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2020
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366791/ https://www.ncbi.nlm.nih.gov/pubmed/32665537 http://dx.doi.org/10.12659/MSM.923507

Ejemplares similares

Thor, with angels : a play /
por: Fry, Christopher, 1907-2005
Publicado: (1948)

NeuTHOR Station—A Novel Integrated Platform for Monitoring BNCT Clinical Treatment, Animal and Cell Irradiation Study at THOR
por: Huang, Yu-Shiang, et al.
Publicado: (2023)

Long Non-Coding RNA THOR Depletion Inhibits Human Non-Small Cell Lung Cancer Cell Growth
por: Jiao, Peng-Fei, et al.
Publicado: (2021)

Effect of lncRNA THOR on proliferation and migration of colon cancer cells
por: Lv, Ying, et al.
Publicado: (2019)

β-Catenin Is Required for the Tumorigenic Behavior of Triple-Negative Breast Cancer Cells
por: Xu, Jinhua, et al.
Publicado: (2015)

The complete mitochondrial genome of Thor amboinensis (Hippolytidae, Decapoda)
por: Wang, Yan, et al.
Publicado: (2020)

Long non-coding RNA THOR promotes ovarian Cancer cells progression via IL-6/STAT3 pathway
por: Ge, Jing, et al.
Publicado: (2020)

LncRNA THOR increases osteosarcoma cell stemness and migration by enhancing SOX9 mRNA stability
por: Wu, Haojun, et al.
Publicado: (2019)

Destabilization of β-catenin and RAS by targeting the Wnt/β-catenin pathway as a potential treatment for triple-negative breast cancer
por: Ryu, Won-Ji, et al.
Publicado: (2020)

THOR-a commodity component prototype for the ATLAS Event Filter
por: Davis, R, et al.
Publicado: (1999)

Cadherin 11 Inhibition Downregulates β-catenin, Deactivates the Canonical WNT Signalling Pathway and Suppresses the Cancer Stem Cell-Like Phenotype of Triple Negative Breast Cancer
por: Satriyo, Pamungkas Bagus, et al.
Publicado: (2019)

PHF21B overexpression promotes cancer stem cell-like traits in prostate cancer cells by activating the Wnt/β-catenin signaling pathway
por: Li, Qiji, et al.
Publicado: (2017)

Inhibiting β-catenin disables nucleolar functions in triple-negative breast cancer
por: Weeks, Shannon E., et al.
Publicado: (2021)

THoR: a tool for domain discovery and curation of multiple alignments
por: Dickens, Nicholas J, et al.
Publicado: (2003)

Differential peak calling of ChIP-seq signals with replicates with THOR
por: Allhoff, Manuel, et al.
Publicado: (2016)

Introducing THOR, a Model Microbiome for Genetic Dissection of Community Behavior
por: Lozano, Gabriel L., et al.
Publicado: (2019)

THOR is a targetable epigenetic biomarker with clinical implications in breast cancer
por: Apolónio, Joana Dias, et al.
Publicado: (2022)

β-catenin and γ-catenin are dispensable for T lymphocytes and AML leukemic stem cells
por: Zhao, Xin, et al.
Publicado: (2020)

MiR-1207 overexpression promotes cancer stem cell–like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway
por: Wu, Geyan, et al.
Publicado: (2015)

Ginsenoside compound K exerts antitumour effects in renal cell carcinoma via regulation of ROS and lncRNA THOR
por: Chen, Shuqiu, et al.
Publicado: (2021)

Lnc-THOR silencing inhibits human glioma cell survival by activating MAGEA6-AMPK signaling
por: Xue, Jun, et al.
Publicado: (2019)

Cell–cell adhesion: linking Wnt/β-catenin signaling with partial EMT and stemness traits in tumorigenesis
por: Basu, Sayon, et al.
Publicado: (2018)

Thor's OS Xodus: why and how I left Windows for OS X
por: Mullen, Timothy M, et al.
Publicado: (2016)

Ecdysone promotes growth of imaginal discs through the regulation of Thor in D. melanogaster
por: Herboso, Leire, et al.
Publicado: (2015)

CUEDC2 Drives β-Catenin Nuclear Translocation and Promotes Triple-Negative Breast Cancer Tumorigenesis
por: Han, Shuyan, et al.
Publicado: (2022)

Niclosamide sensitizes triple-negative breast cancer cells to ionizing radiation in association with the inhibition of Wnt/β-catenin signaling
por: Yin, Lina, et al.
Publicado: (2016)

Odín, Thor, Loki, Frigg, Heimdallr y las Valquirias : Edda poética, Edda prosaica y cuentos nórdicos /

SHP2 Potentiates the Oncogenic Activity of β-Catenin to Promote Triple-Negative Breast Cancer
por: Martin, Elisha, et al.
Publicado: (2021)

The WAVE3/β-catenin oncogenic signaling regulates chemoresistance in triple negative breast cancer
por: Wang, Wei, et al.
Publicado: (2023)

WNT/β-Catenin-Mediated Resistance to Glucose Deprivation in Glioblastoma Stem-like Cells
por: Yusuf, Suad, et al.
Publicado: (2022)

CRB3 downregulation confers breast cancer stem cell traits through TAZ/β-catenin
por: Li, P, et al.
Publicado: (2017)

Kruppel-like factor 8 regulates triple negative breast cancer stem cell-like activity
por: Le Minh, Giang, et al.
Publicado: (2023)

THOR’s Hammer: the Antibiotic Koreenceine Drives Gene Expression in a Model Microbial Community
por: Hurley, Amanda, et al.
Publicado: (2022)

Differential DNA Methylation of THOR and hTAPAS in the Regulation of hTERT and the Diagnosis of Cancer
por: Ott, Pauline, et al.
Publicado: (2022)

LIPH promotes metastasis by enriching stem‐like cells in triple‐negative breast cancer
por: Zhang, Yixiao, et al.
Publicado: (2020)

Role of microRNA/lncRNA Intertwined With the Wnt/β-Catenin Axis in Regulating the Pathogenesis of Triple-Negative Breast Cancer
por: Hu, Xue, et al.
Publicado: (2022)

TUFT1 Promotes Triple Negative Breast Cancer Metastasis, Stemness, and Chemoresistance by Up-Regulating the Rac1/β-Catenin Pathway
por: Liu, Weiguang, et al.
Publicado: (2019)

miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/β-catenin signalling pathway
por: Ge, Chunlei, et al.
Publicado: (2015)

Interference KRT17 reverses doxorubicin resistance in triple-negative breast cancer cells by Wnt/β-catenin signaling pathway
por: Wu, Liqiong, et al.
Publicado: (2023)

BET degrader inhibits tumor progression and stem-like cell growth via Wnt/β-catenin signaling repression in glioma cells
por: Tian, Tao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_16t6o26hnat33kfbfaqkrc0v0e